poster

A Competitive Ligand-binding Assay for the Detection of Neutralizing Antibodies Against XTMAB-16

Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with acceptable drug and target tolerances to guide future clinical trials.